This study highlights the epigenetic disruption of an enhancer targeting TET2, a key regulator of DNA methylomes (Figure 2), as well as dysregulation in enhancers of PD risk genes such as DNAJC6, DCTN1, PRKN, PLA2G6 and FBXO7. The gene discussed is TET2; the disease is Parkinson disease.